PSY124 - Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis: A Cross-Country Review of Access Conditions
Autor: | Picavet, E, Soulard, S, Druez, C, Munack, U |
---|---|
Zdroj: | In Value in Health October-November 2017 20(9):A566-A566 |
Databáze: | ScienceDirect |
Externí odkaz: |